BioLife Solutions Inc (BLFS.OQ)
7.33USD
20 Apr 2018
-- (--)
$7.33
--
--
--
--
19,478
$7.83
$2.01
Mon, Apr 9 2018
BRIEF-Casdin Capital To Become Shareholder In Biolife Solutions
* CASDIN CAPITAL LLC, ENTERED INTO AN AGREEMENT TO PURCHASE 1,000,000 BIOLIFE SOLUTIONS SHARES IN PRIVATE DEAL Source text for Eikon: Further company coverage:
BRIEF-BioLife Solutions Announces Preliminary Q1 Revenue Of $3.8 Mln, Up 61 Pct
* FOR 2018 BIOPRESERVATION MEDIA REVENUE EXPECTED TO RANGE BETWEEN $14.5 MILLION TO $15.5 MILLION
BRIEF-BioLife Solutions Q4 Loss Per Share $0.05
* BIOLIFE SOLUTIONS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
BRIEF-Biolife Solutions Executes OEM Agreement With MilliporeSigma
* BIOLIFE SOLUTIONS EXECUTES OEM AGREEMENT WITH MILLIPORESIGMA Source text for Eikon: Further company coverage:
BRIEF-Biolife Solutions Says Co And Savsu Technologies Amended Their Arrangement With Respect To JV
* BIOLIFE SOLUTIONS SAYS ON JAN 22 CO AND SAVSU TECHNOLOGIES AMENDED THEIR ARRANGEMENT WITH RESPECT TO THEIR JV, BIOLOGISTEX- SEC FILING
BRIEF-Biolife Solutions Executes Supply Agreement With Iovance Biotherapeutics
* BIOLIFE SOLUTIONS EXECUTES SUPPLY AGREEMENT WITH IOVANCE BIOTHERAPEUTICS
BRIEF-Biolife Solutions Executes Additional Long-Term Supply Agreement With Leading T Cell Therapy Customer
* BIOLIFE SOLUTIONS EXECUTES ADDITIONAL LONG-TERM SUPPLY AGREEMENT WITH LEADING T CELL THERAPY CUSTOMER Source text for Eikon: Further company coverage:
BRIEF-BioLife Solutions posts Q3 loss per share $0.03
* Biolife Solutions announces third quarter 2017 financial results
BRIEF-Biolife Solutions to report Q3 results and provide business update on Nov 9
* Biolife Solutions to report third quarter 2017 financial results and provide business update on November 9, 2017 Source text for Eikon: Further company coverage: